Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Development of an instrumented hammer to assess the stability of hip implant during surgery: assessment of the commercial feasibility

Descripción del proyecto

Nuevo dispositivo para supervisar el éxito de las artroplastias de cadera

La patología degenerativa de cadera no es nada nuevo. Paleontólogos y arqueólogos han descubierto signos de caderas artrósicas en esqueletos de «Homo neanderthalensis». En siglos anteriores, los pacientes se las arreglaban con bastones y muletas hasta que ya no podían más. Hoy en día, la artroplastia total de cadera es un procedimiento común. Se reemplazan tanto la cabeza del fémur (la bola en la parte superior del hueso del muslo) como el acetábulo (la cavidad de la cadera). Sin embargo, todavía se producen problemas debido a una mala estabilidad primaria del implante o a fracturas. En este contexto, el equipo del proyecto Impactor, financiado por el Consejo Europeo de Investigación, desarrollará un producto sanitario que permitirá a los cirujanos evaluar la estabilidad de la copa acetabular y el vástago femoral.

Objetivo

Total hip replacement is widely used by orthopedic surgeons, with more than one million procedures per year worldwide. Failures still occur because of a bad implant primary stability or to the occurrence of fractures, inducing pain and increased costs for the healthcare system. Although implant primary stability is the main determinant of the implant success, it remains difficult to be assessed in clinical practice.
Impactor is based on results obtained in the ERC CoG project BoneImplant and aims at developing and validating a medical device consisting in a decision support-system allowing the surgeon to assess the stability the acetabular cup and of the femoral stem. Such medical device is needed by the clinicians in order to adapt their surgical strategy. The objective of Impactor is i) to achieve a minimum viable product (MVP) that will be validated in vitro and in anatomical subjects, and ii) to investigate its commercial potential and design a subsequent commercial exploitation strategy via spin-off creation or licensing of the technology. We will explore the possibility to license the technology to WaveImplant, an already existing spin-off of the same laboratory. The originality of the approach is to use an orthopedic hammer instrumented with piezoelectric sensors, which does not modify the clinical protocol since implants are impacted in bone.
Regulatory issues will be at the heart of the development and we will work in order to clear the regulatory pathway of the future medical device. The team is constituted by members with complementary skills (including engineers, a business developer and an orthopedic surgeon expert in implantology).
Impactor will allow the promotion of innovative solution and services in orthopedic surgery. The long-term vision is for the technology to become a reference in orthopedic surgery. Strong impacts are associated to Impactor, in particular for surgeons, patients, implant manufacturers, the technology and the economy.

Ámbito científico

CORDIS clasifica los proyectos con EuroSciVoc, una taxonomía plurilingüe de ámbitos científicos, mediante un proceso semiautomático basado en técnicas de procesamiento del lenguaje natural.

Institución de acogida

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Aportación neta de la UEn
€ 150 000,00
Dirección
RUE MICHEL ANGE 3
75794 Paris
Francia

Ver en el mapa

Región
Ile-de-France Ile-de-France Paris
Tipo de actividad
Research Organisations
Enlaces
Coste total
Sin datos

Beneficiarios (1)